02359.HK
WuXi AppTec Co., Ltd.
HKSE · Healthcare · Medical - Diagnostics & Research · CN
HKD 185.40
−2.98%Year over year
Reported trailing growth
- Revenue
- +30.8%
- EBITDA
- +67.3%
- EBIT
- +41.7%
- EPS
- +72.2%
- Free cash flow
- +51.6%
- Operating cash flow
- +47.5%
Forward estimates
Based on analyst estimates
- Revenue
- +21.3%
- EBITDA
- +2.7%
- EPS
- -13.3%
Three-year CAGR
- Revenue
- +4.9%
- EBITDA
- +30.6%
- EBIT
- +16.9%
- Net income
- +29.5%
- EPS
- +28.6%
- Free cash flow
- +161.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026